Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects
Human Gene Therapy · 01.08.2026
DOI: 10.1177/10430342261466427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, online erschienen am 01.08.2026. Verfasst von Laura Blaha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Medicine Unit, Sanofi, Waltham, Massachusetts, USA. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Sanofi.
Abstract (Originalsprache)
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology has revolutionized genetic medicine by enabling precise genome editing for therapeutic benefit. CRISPR nucleases are programmed to target genomic sites with sequence complementarity to the spacer region of an associated guide RNA. However, these nucleases may target genomic loci with sequences similar to the target site, which can lead to unintended disruption of off-target genes. The risks associated with these off-target editing events are critical to assess as CRISPR-based in vivo editing systems advance to clinical development. Nonhuman primates (NHPs) are common model species for evaluating the human safety of many therapeutic modalities, but their relevance for evaluating human CRISPR off-target activity has yet to be determined. In this study, 1,220,908 Cas12a and 6,159,066 Cas9 spacer sequences targeting human genes were designed, and off-target editing sites were computationally predicted in humans and five common NHP species. Of the 7,413 Cas12a and 570,754 Cas9 spacers meeting defined on- and off-target inclusion criteria, only 14–21% of Cas12a and 7–15% of Cas9 human off-targets per spacer are recapitulated in the genomes of NHPs commonly used in preclinical studies. These results highlight the limitations of NHPs for the study of human CRISPR spacer specificity and contextualize human risk informed by these studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genomic Medicine Unit, Sanofi, Waltham, Massachusetts, USA.
- Diamond Age Data Science, Boston, Massachusetts, USA.
ORCID-Profile: Christian Mueller
Förderung
- Sanofi
Zitieren
APA
Blaha, L., Bosinger, M., Bodian, D. L., Qu, V., Warner, J. B., Borges, C. M., & Mueller, C. (2026). Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects. Human Gene Therapy. https://doi.org/10.1177/10430342261466427
Vancouver
Blaha L, Bosinger M, Bodian DL, Qu V, Warner JB, Borges CM, et al. Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects. Human Gene Therapy. 2026. doi:10.1177/10430342261466427
BibTeX
@article{Blaha2026,
author = {Blaha, Laura and Bosinger, Mia and Bodian, Dale L and Qu, Victoria and Warner, Jason B and Borges, Christopher M and Mueller, Christian},
title = {Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects},
journal = {Human Gene Therapy},
year = {2026},
doi = {10.1177/10430342261466427}
}
EUVIMED